Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.FDA grants fast track status to Nacuity’s NPI-001 for retinitis pigmentosa
The fast track status is granted to drugs which show potential in treating a serious or life-threatening condition. Credit: Myriam Zilles on Unsplash.
The fast track status is granted to drugs which show potential in treating a serious or life-threatening condition. Credit: Myriam Zilles on Unsplash.